NCT02171013View on ClinicalTrials.gov

Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2006

Conditions
Healthy
Interventions
DRUG

Dabigatran polymorph I (≈ 83%) and polymorph II (≈17%)

DRUG

Dabigatran polymorph I

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY